Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Nature of expenses (Tables)

v3.19.1
Nature of expenses (Tables)
12 Months Ended
Dec. 31, 2018
Expenses by nature [abstract]  
Disclosure of research and development
 
2018
$

 
2017
$

Research and development
 
 
 
Contract research organizations (CROs) and other third party clinical trial expenses
27,923

 
21,634

Drug supply and distribution
4,893

 
7,124

Salaries, incentive pay and employee benefits
4,260

 
3,065

Stock compensation expense
2,697

 
993

Travel, insurance, patent annuity fees, legal fees and other

1,609

 
1,114

 
41,382

 
33,930

Disclosure of administrative expenses

2018
$

 
2017
$

Corporate, administration and business development

 

Salaries, incentive pay, director fees and employee benefits
4,600

 
4,239

Stock compensation expense
4,163

 
3,249

Professional and consulting fees
2,307

 
2,125

Rent, insurance, information technology and other public company operating costs
1,704

 
1,327

Travel, tradeshows and sponsorships
900

 
1,156


13,674

 
12,096